Explore Our Diverse Range Of Offerings
From detailed reports to experts services offered in 15+ Industry Domains
Report
Press Release
Blogs
Industry Statistics
Add 2 More Reports For 20% off

Report Overview

2024

Base Year

2018-2024

Historical Year

2025-2034

Forecast Year

Global Head and Neck Cancer Therapeutics Market Outlook

The global head and neck cancer therapeutics market size reached a value of USD 1.67 billion in 2024, driven by the rising prevalence of cancer. The market is expected to grow at a CAGR of 11.2% during the forecast period of 2025-2034, likely to attain a value of around USD 4.32 billion by 2034.

Head and Neck Cancer Therapeutics: Introduction

Head and neck cancer can be inclusive of different cancers, including throat cancer, voice box cancer, and mouth cancer, among others. These squamous cell cancers usually form up in the salivary glands or sinuses.  Head and neck cancer can be treated if they are diagnosed timely. Different approaches are taken to treat these cancers, depending on the symptoms and severity of the condition. The therapeutic process has to be decided carefully, with the primary goal of removing the tumour. It should also be ensured that the functioning of the nearby nerves, organs, and tissues is not hampered by the treatment process.

The therapeutic options for head and neck cancer can be categorised into chemotherapy, radiation therapy, immunotherapy, targeted therapy, and surgery, depending on what would suit the patient and work more efficiently for them.

Key Trends in the Head and Neck Cancer Therapeutics Market

The growth of the market is primarily driven by the rising demand for treatment with the rapidly rising prevalence of cancers across the globe. The growing demand for innovative and effective therapies has been aiding the development of the market. The rising prevalence of cancer can be majorly attributed to the rising consumption of tobacco-based products like cigarettes, and the rising prevalence of alcoholism. The emergence of new and advanced technology is also anticipated to bolster the demand for the therapeutics.

Global Head and Neck Cancer Therapeutics Market Analysis

Based on type, the market is divided into therapy type, route of administration, distribution channel, and region.

Market Breakup by Therapy Type

  • Chemotherapy 
  • Immunotherapy 
  • Targeted Therapy 
  • Radiation Therapy

Market Breakup by Route of Administration

  • Oral 
  • Parenteral

Market Breakup by Distribution Channel

  • Hospital Pharmacies  
  • Drug Stores and Retail Pharmacies  
  • Online Pharmacies

Market Breakup by Region

  • North America 
  • Europe 
  • Asia Pacific 
  • Latin America 
  • Middle East and Africa

Global Head and Neck Cancer Therapeutics Market Scenario

The growth of the head and neck cancer therapeutics market is driven by a variety of factors. Based on regions, North America has been dominating the global market and it is likely that the region will continue its dominance over the coming years as well. The rapid development of the healthcare sector, along with the rising support from the government and technological advancement, is anticipated to propel significant impetus to the growth of the market.

Head and Neck Cancer Therapeutics Market: Competitive Landscape

The comprehensive EMR report provides an in-depth assessment of the market based on Porter's five forces model, along with giving a SWOT analysis. The report gives a detailed analysis of the following key players in the global head and neck cancer therapeutics market, covering their competitive landscape and the latest developments like mergers, acquisitions, investments, and expansion plans.

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players.

  • AstraZeneca Plc.
  • Bristol-Myers Squibb Company  
  • Eli Lilly and Company  
  • F. Hoffmann-La Roche Ltd. (Genentech, Inc.)  
  • Fresenius Medical Care AG & Co. KGaA 
  • Merck & Co., Inc.  
  • Pfizer Inc.  
  • Sanofi  
  • Sun Pharmaceutical Industries Ltd.  
  • Teva Pharmaceutical Industries Limited

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2018-2024
Forecast Period 2025-2034
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Therapy Type
  • Route of Administration
  • Distribution Channel
  • Region
Breakup by Therapy Type
  • Chemotherapy 
  • Immunotherapy 
  • Targeted Therapy 
  • Radiation Therapy
Breakup by Route of Administration
  • Oral 
  • Parenteral
Breakup by Distribution Channel
  • Hospital Pharmacies  
  • Drug Stores and Retail Pharmacies  
  • Online Pharmacies
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • AstraZeneca Plc.
  • Bristol-Myers Squibb Company  
  • Eli Lilly and Company  
  • F. Hoffmann-La Roche Ltd. (Genentech, Inc.)  
  • Fresenius Medical Care AG & Co. KGaA 
  • Merck & Co., Inc.  
  • Pfizer Inc.  
  • Sanofi  
  • Sun Pharmaceutical Industries Ltd.  
  • Teva Pharmaceutical Industries Limited

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Key Questions Answered in the Report

The market attained a value of USD 1.67 billion in 2024, driven by the rising cases of neurovascular diseases across the globe.

The market is anticipated to grow at a CAGR of 11.2% during the forecast period of 2025-2034 to attain a value of around USD 4.32 billion by 2034.

The growth of the market is driven by factors like rising awareness about the disease, the increasing availability of the treatment, and the rapid technological advancements.

The key trends which are bolstering the market growth include the rising investment and fundings by government and healthcare organizations.

The major regional markets include North America, Europe, Asia Pacific, Latin America, Middle East and Africa.

The therapy types in the market include chemotherapy, immunotherapy, targeted therapy, and radiation therapy.

The routes of administration include oral and parenteral routes.

The key players in the market can be categorised into AstraZeneca Plc., Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche Ltd. (Genentech, Inc.), Fresenius Medical Care AG & Co. KGaA, Merck & Co., Inc., Pfizer Inc., Sanofi, Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Limited.

Datasheet

10 % Off

USD

3,299

2,969

Single User License

10 % Off

USD

5,499

4,949

Five User License

15 % Off

USD

6,999

5,949

Corporate License

15 % Off

USD

8,199

6,969

Datasheet

One User

USD 3,299

USD 2,969

tax inclusive*

  • Selected Segments
  • Printing Restrictions
  • Excel Spreadsheet Delivered via Email
  • Full Report
  • Periodic Updates
  • Post Sales Analysts Support
  • Unlimited Prints

Single User License

One User

USD 5,499

USD 4,949

tax inclusive*

  • All Segments
  • Printing Restrictions
  • PDF Delivered via Email
  • Custom Report Layout
  • Post Sales Analysts Support
  • Periodic Updates
  • Unlimited Prints

Five User License

Five User

USD 6,999

USD 5,949

tax inclusive*

  • All Segments
  • Five Prints Available
  • PDF Delivered via Email
  • Limited Free Customization
  • Post Sales Analyst Support
  • Custom Report Layout
  • Periodic Updates
  • Unlimited Prints

Corporate License

Unlimited Users

USD 8,199

USD 6,969

tax inclusive*

  • All Segments
  • Unlimited Prints Available
  • PDF & Excel Delivery via Email
  • Limited Free Customization
  • Post Sales Analysts Support
  • Discount On Next Update
  • Custom Report Layout

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Bundle Type

Flash Bundle

20% OFF Number of Reports: 3

Small Business Bundle

25% OFF Number of Reports: 5

Growth Bundle

30% OFF Number of Reports: 8

Enterprise Bundle

35% OFF Number of Reports: 10
Overview
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complementary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complementary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 80 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complementary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 100 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complementary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Flash Bundle

Number of Reports: 3

20%

tax inclusive*

  • 3 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade
  • Free Analyst Hours

Small Business Bundle

Number of Reports: 5

25%

tax inclusive*

  • 5 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade

Growth Bundle

Number of Reports: 8

30%

tax inclusive*

  • 8 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Free Analyst Hours - 80 Hours
  • Power BI Dashboards

Enterprise Bundle

Number of Reports: 10

35%

tax inclusive*

  • 10 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Power BI Dashboards
  • Free Analyst Hours - 100 Hours

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


Australia

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63-287-899-028, +63-967-048-3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

United States

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.

+63-287-899-028, +63-967-048-3306

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124